Faculty of Medicine Research Report 2014-2015

Research Report 2014/15
Research: Funding Trends
82 Patents
25 Departments
790M Total Funding
9118 Total Awards
Research in the University of Toronto’s Faculty of Medicine spans ten Toronto sites, collectively known as the Toronto Academic Health Sciences Network (TAHSN).
Partners include the Downtown Toronto (St. George) campus of University of Toronto (UofT) and nine affiliated academic hospitals: Baycrest Health Sciences, the
Centre for Addiction and Mental Health (CAMH), Holland Bloorview Kids Rehabilitation Hospital, The Hospital for Sick Children (SickKids), Sinai Health System,
St. Michael’s Hospital, Sunnybrook Health Sciences Centre, University Health Network (UHN) and Women’s College Hospital (WCH).
Total Funding per Site by Year
Total Funding per Site 2014/15
3.2M
Baycrest
67.8M Sunnybrook
5.4M Holland Bloorview
31.7M
CAMH
6.4M
WCH
104.6M St. George
248.6M
UHN
42.7M
St. Mike’s
152.7M
Sick Kids
55.9M Sinai Health System
Faculty of Medicine Sites
in Downtown Toronto
2013-14
2012-13
2011-12
2010-11
$250M
2010-11, 2011-12, 2012-13, 2013-14
$200M
$100M
Total Funding per Department by Year
$150M
Site off map
$50M
Site
2014-15
2014-15
$150M
$125M
$100M
$75M
$50M
Surgery
Speech-Language Pathology
Radiation Oncology
Psychiatry
Physiology
Physical Therapy
Pharmacology & Toxicology
Paediatrics
Otolaryngology
Occupational Science & Therapy
Obstetrics & Gynaecology
Nutritional Sciences
Molecular Genetics
Medicine
Medical Imaging
Medical Biophysics
Immunology
IBBME
Ophthalmology & Vision Sciences
400
Lab MEdicine & PathoBiology
200
Family & Community Medicine
150
Donnelly Centre
100
Biochemistry
50
Anesthesia
$25M
Number of Funded Primary Investigators by Department (2014/15)
A Message From the Vice Dean Research and Innovation
The University of Toronto’s Faculty of Medicine is Canada’s leader in medical discovery research and clinical innovation. This
report outlines our impressive research impact and growth for 2014-2015, a year which further strengthened partnerships
between the University of Toronto and its nine fully affiliated hospitals. In particular, this year brought new opportunities for
major research impacts in cardiovascular health through the Ted Rogers Centre for Heart Research, a collaboration between
the University of Toronto, the Hospital for Sick Children, and University Health Network. As we celebrate our research
achievements and partnerships, we invite you to join us in the years to come as we continue to break new ground in research
and put our ideas into action.
- Alison Buchan, PhD, FCAHS
Strategic Research Funding
Research Themes
Research Platforms
Funding in Millions
Funding in Millions
HEALTH 2014/15
INFORMATICS 2013/14
2012/13
2011/12
2010/11
2014/15 HUMAN
2013/14 DEVELOPMENT
2012/13
2011/12
2010/11
FUNCTIONAL 2014/15
IMAGING 2013/14
2012/13
2011/12
2010/11
2014/15 GLOBAL HEALTH
2013/14
2012/13
2011/12
2010/11
CELL & SYSTEMS 2014/15
BIOLOGY 2013/14
2012/13
2011/12
2010/11
2014/15 NEUROSCIENCES
2013/14 & BRAIN HEALTH
2012/13
2011/12
2010/11
OMICS 2014/15
2013/14
2012/13
2011/12
2010/11
KNOWLEDGE 2014/15
EXCHANGE 2013/14
2012/13
2011/12
2010/11
2014/15 COMPLEX
2013/14 DISORDERS
2012/13
2011/12
2010/11
Preparing for Success
Development
Grant
Researcher
0
M
$25
M
$50
M
$75
0M
$10
5M
0M
$12
$15
0M
5M
$17
$20
0M
$35
5M
0M
$37
$40
0M
$35
0M
$25
0M
$20
0M
0M
$15
$10
M
$50
Grant
Cycle
M
$25
0
Peer review
Grant & program development Service
(est. 2011)
April 2014 - March 2015
129 proposals edited for 17 agencies
86 researcher clients (41% of St. George Campus
researchers)
27% CIHR success rate for operating grants
(vs. 15% national success rate)
$25,708,000 in research funding
All Data from the Faculty of Medicine,
Office of the vice Dean,
Research and Innovation
www.medicine.utoronto.ca/research
Design by Alexandra Papaelias &
Jamie McMillan
International Collaborations: Publications
Faculty of Medicine researchers collaborate with peers at leading universities across Canada and around the world. In the map below, the colour scale
indicates the number of collaborations between FoM researchers and researchers in our partner countries in 2014. The percentages represent the
proportion of FoM internationally co-authored publications by country.
3%
5%
10%
5%
2%
7%
5%
3%
33%
Number of Collaborations
with FOM Researchers
1000+
500-999
300-499
200-299
100-199
3%
2%
2%
2%
2%
7%
Benchmarking
1.7
1.68
1.70
1.8
1.86
1.9
1.79
UofT Publication Impact
1.75
The Faculty of Medicine’s research output and impact rank the highest among medical research
centers in Canada, and compete with best-in-class institutions worldwide. The faculty’s publication
output is double that of other major Canadian universities, our research ranks in the top 1 percent
by citations among publicly funded universities globally, and measures of our publication impact
are consistently well over the global average.
1.6
1.5
2014 Global and Domestic Health Publication Output
1.4
1.3
1.2
1.1
5000
16,529
9659
1000
1000
736 Neuroscience
623 Clinical Neurology
446 Psychiatry
10,726
2000
3000
4000
# of International Collaborations
UofT
UCL
Oxford
McGill
UBC
UCLA
2014
2014 Output of Publications
in Strategic Areas
23,258
3000
5571
2013
18,622
2012
0.9
2011
15,790
7000
Global
Average
1.0
20,101
2010
# of Web of Science Documents
9000
Michigan
UofA
# of Citations
5000
766 Oncology
354 Cardiac & Cardiovascular
512 Biochemistry & Molecular
Biology
369 Cell Biology
Commercialization
Patent Applications by Department
Patent Applications by Site
10
5
5
Anesthesia
Biochemistry
Donnelly Centre
Family & Community Medicine
IBBME
Immunology
Lab MEdicine & Pathobiology
Medical Biophysics
Medical Imaging
Medicine
Molecular Genetics
Nutritional Sciences
Obstetrics & Gynaecology
Occupational Science & therapy
Otolaryngology
Paediatrics
Pharmacology & Toxicology
Physiology
Psychiatry
Radiation Oncology
Speech-Language Pathology
Surgery
UHN
10
Sunnybrook
15
St. Mike’s
15
St. George
20
Sick Kids
20
Sinai Health
system
25
CAMH
25
Holland
Bloorview
30
Baycrest
30
Includes all patent applications (excluding renewal or updates over the past 6 years) with University
of Toronto or an affiliated hospital as an applicant and FOM faculty as inventors as obtained from
the PATENTSCOPE database of the World Intellectual Property Organization. For patents with
multiple University of Toronto applicants, all sites and departments received credit.
2014/15
Partners in Innovation
CANADA
Institut de Recherches Cliniques de Montreal
McGill Univeristy
Université de Montréal
University of British Columbia
Western University
USA
COLUMBIA UNIVERSITY
JOHNS HOPKINS UNIVERSITY
NEW YORK UNIVERSITY
NORTHWESTERN UNIVERSITY
UNIVERSITY OF CALIFORNIA
UNIVERSITY OF CHICAGO
UNIVERSITY OF MARYLAND, BALTIMORE
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
UNIVERSITY OF TEXAS
TUFTS UNIVERSITY
Benchmarking Data
Ranking information is based on data obtained from the Association of University Technology Managers (AUTM).
Totals
U of T All
U of T All
FoM & Hospitals U of T All Canadian Rank North American Rank Top Institutions
Invention
Disclosures
312
432
1
5
MIT
Stanford Univ.
Johns Hopkins Univ.
1
2
3
Licenses
107
143
1
7
Univ. of Washington Seattle
Univ. of Minnesota
Univ. of Pittsburgh
1
2
3
Start-Ups
8
27
1
1
Hospitals + UofT combined 1
Purdue Research Fdn.
2
Stanford Univ.
3
INTERNATIONAL
Charite University Hospital
King Saud University
Vilnius University
INDUSTRY
Apotex
Beckman Coulter
Cellaegis Devices
Colibri Technologies
Forticelle
GSK
Kraft
Roche
Tecan
Toshiba
2010-2014 Average
University systems not included
Faculty-Wide Benchmarking
2015/16
2014/15
Times Higher Education (Clinical, Pre-Clinical & Health)
11
13
QS World University Ranking (Medicine)
13
14
National Taiwan University Ranking (Medicine)
3
3
Featured Awardees 2014
Daniel J. Drucker, OC, MD, FRS, FRSC, FRCPC
Professor, Department of Medicine
Senior Investigator, Lunenfeld-Tanenbaum Research Institute, Sinai Health System
Officer of the Order of Canada
Fellow of the Royal Society
Dr. Daniel Drucker is a world leader in the translational biology of gastrointestinal hormones. His pioneering studies of
gut hormone action have enabled development of three new classes of medications for the treatment of diabetes, obesity
and short bowel syndrome (SBS), including teduglutide, the first glucagon-like-peptide-2 analogue approved for treatment
of SBS. Dr. Drucker is the first Canadian researcher to be honoured with the Manpei Suzuki International Prize, the
world’s most valuable prize for diabetes research, and was appointed to the Order of Canada “for his contributions to the
development of medicines used around the world to treat diabetes and intestinal disorders.”
Angela Colantonio, PhD, FACRM, FCAHS
Professor, Department of Occupational Science and Occupational Therapy
Director, Rehabilitation Sciences Institute
Senior Scientist, UHN - Toronto Rehabilitation Institute
Fellow of the Canadian Academy of Health Sciences
“Dr. Angela Colantonio leads a broad, internationally recognized program of research on acquired brain injury (ABI)
examining ABI in the population, targeting injury prevention and post-acute care with a special focus on how ABI impacts
the lives of those most vulnerable to health service inequities, such homeless and older adults and high-risk workers.
Dr. Colantonio's research program also examines work-related TBI, long term outcomes among women with ABI, the
impact of sex/gender on outcomes, and innovative approaches to intervention, such as the use of theatre as a knowledge
mobilization strategy.” – University of Texas Medical Branch
Arthur S. Slutsky, MD, MASc, FRSC, FCAHS
Professor, Department of Medicine
Vice President, Research, St. Michael’s Hospital
2014 CIHR Health Researcher of the Year
Fellow of the Royal Society of Canada
Dr. Arthur Slutsky was named Canadian Institutes of Health Research (CIHR) Health Researcher of the Year in honour of
his outstanding research in critical care medicine and pulmonary care. Dr. Slutsky “has made important discoveries
related to the benefits and complications of mechanical ventilation, a life-sustaining therapy in critically ill patients. He
has published over 450 peer-reviewed articles and his innovative work has played a major role in improving the way
that mechanical ventilation is delivered, resulting in decreased mortality in patients with respiratory failure.” – Royal
Society of Canada
Anne-Claude Gingras, PhD, FRSC
Professor, Department of Molecular Genetics
Senior Investigator, Lunenfeld-Tanenbaum Research Institute, Sinai Health System
Fellow of the Royal Society of Canada
“Dr. Anne-Claude Gingras is an internationally recognized leader in the field of systems biology, having developed and
applied innovative new technologies and analysis tools for understanding complex protein-protein interactions associated
with human diseases. Her tools and data analysis methods are used by researchers across the globe.” – Royal Society of
Canada